Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The number of medical research studies at Oxford University Hospitals NHS Foundation Trust has hit a record high, new figures show.

The number of studies active in May 2016 was 1,786, up seven per cent from 1,664 in May 2015.

The figures – up 222 per cent from 554 in May 2008 – show a significant increase in studies hosted by OUH for areas such as cancer, vaccines and cardiovascular conditions.

Many studies are carried out with the University of Oxford at the Trust, which runs Oxford’s John Radcliffe and Churchill hospitals and the Nuffield Orthopaedic Centre and Banbury’s Horton General Hospital.

Read more (Oxford University Hospitals NHS Trust)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.